University of Pittsburgh Graduate School of Public Health, Pennsylvania, USA.
Am J Cardiol. 2012 Oct 15;110(8):1130-7. doi: 10.1016/j.amjcard.2012.05.054. Epub 2012 Jun 27.
Primary prevention guidelines recommend calculation of lifetime cardiovascular disease (CVD) predicted risk in patients who may not meet criteria for high short-term (10-year) Adult Treatment Panel III risk for coronary heart disease (CHD). Extreme obesity and bariatric surgery are more common in women who often have low short-term predicted CHD risk. The distribution and correlates of lifetime CVD predicted risk, however, have not yet been evaluated in bariatric surgical candidates. Using established 10-year (Adult Treatment Panel III) CHD and lifetime CVD risk prediction algorithms and presurgery risk factors, participants from the Longitudinal Assessment of Bariatric Surgery-2 study without prevalent CVD (n = 2,070) were stratified into 3 groups: low 10-year (<10%)/low lifetime (<39%) predicted risk, low 10-year (<10%)/high lifetime (≥39%) predicted risk, and high 10-year (≥10%) predicted risk or diagnosed diabetes. Participants were predominantly white (86%) and women (80%) with a median age of 45 years and median body mass index of 45.6 kg/m(2). High 10-year CHD predicted risk was common (36.5%) and associated with diabetes, male gender, and older age, but not with higher body mass index or high-sensitivity C-reactive protein. Most participants (76%) with low 10-year predicted risk had high lifetime CVD predicted risk, which was associated with dyslipidemia and hypertension but not with body mass index, waist circumference, high-density lipoprotein cholesterol, or high-sensitivity C-reactive protein. In conclusion, bariatric surgical candidates without diabetes or existing CVD are likely to have low short-term, but high lifetime CVD predicted risk. Current data support the need for long-term monitoring and treatment of increased CVD risk factors in bariatric surgical patients to maximize lifetime CVD risk decrease (clinical trial registration, Long-term Effects of Bariatric Surgery, indentifier NCT00465829, available at: http://www.clinicaltrials.gov/ct2/results?term=NCT00465829).
一级预防指南建议对不符合高短期(10 年)成人治疗小组 III 冠心病(CHD)高危标准的患者计算终生心血管疾病(CVD)预测风险。在短期预测 CHD 风险较低的女性中,极度肥胖和减肥手术更为常见。然而,在减肥手术候选者中,尚未评估终生 CVD 预测风险的分布和相关性。使用既定的 10 年(成人治疗小组 III)CHD 和终生 CVD 风险预测算法以及术前风险因素,来自纵向评估减肥手术-2 研究的无现有 CVD(n = 2070)参与者分为 3 组:低 10 年(<10%)/低终生(<39%)预测风险,低 10 年(<10%)/高终生(≥39%)预测风险,以及高 10 年(≥10%)预测风险或诊断糖尿病。参与者主要为白人(86%)和女性(80%),中位年龄为 45 岁,中位体重指数为 45.6kg/m2。高 10 年 CHD 预测风险很常见(36.5%),与糖尿病、男性性别和年龄较大相关,但与体重指数较高或高敏 C 反应蛋白无关。大多数低 10 年预测风险的参与者(76%)具有高终生 CVD 预测风险,这与血脂异常和高血压有关,但与体重指数、腰围、高密度脂蛋白胆固醇或高敏 C 反应蛋白无关。总之,无糖尿病或现有 CVD 的减肥手术候选者可能具有低短期但高终生 CVD 预测风险。目前的数据支持在减肥手术患者中需要长期监测和治疗增加的 CVD 危险因素,以最大程度地降低终生 CVD 风险(临床试验注册,减肥手术的长期影响,标识符 NCT00465829,可在以下网址获得:http://www.clinicaltrials.gov/ct2/results?term=NCT00465829)。